ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Uniform Microscale Thermoresponsive Liposomes for Controlled Release Above Body Temperature.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Stimuli-responsive delivery systems, particularly thermoresponsive platforms, are becoming increasingly important for physiological applications, but their development has been limited by poor biocompatibility, slow response, and non-scalable fabrication methods. Liposomes offer a biocompatible and adaptable foundation for this need, but no scalable approach exists to produce uniform thermosensitive liposomes that activate above 37°C. Here, we present the first scalable strategy for generating monodisperse thermoresponsive liposomes using a corona-discharge- treated PDMS double-emulsion device. Aqueous cargo-containing cores are encapsulated within DPPC-containing oleic acid shells, with Pluronic F-127 added to the outer phase to stabilize the interface. Ethanol-mediated solvent extraction transforms these shells into lipid bilayers, and the combined use of rotational mixing and surfactant-assisted interfacial tuning reduces extraction time by more than 50% compared with prior reports while ensuring complete bilayer formation, even for thick shells. Under regulated extraction, droplets with thin lipid membranes incorporating Pluronic F-127 undergo abrupt rupture and cargo release at ∼41°C-45°C, providing stable encapsulation at physiological temperature and sharp thermally triggered release above body temperature. Overall, this work creates the first platform capable of producing uniform thermoresponsive liposomes that undergo abrupt, super-physiological temperature-triggered release, providing broad potential for drug delivery, biosensing, and synthetic biology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.